Inactive Instrument

Insiders Transcept Pharmaceuticals Inc Nasdaq

Equities

US89354M1062

End-of-day quote Nasdaq Other stock markets
- ^USD	-

03-05	Paratek Pharmaceuticals Announces Positive Efficacy Data for Nuzyra® as Post-Exposure Prophylaxis of Inhalational Anthrax, Triggering Additional Procurement Under Barda Project Bioshield Contract	CI
01-16	Paratek Pharmaceuticals, Inc. Promotes Jonathan Light to General Counsel, Corporate Secretary and Chief Compliance Officer	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Paratek Pharmaceuticals, Inc. Promotes Jonathan Light to General Counsel, Corporate Secretary and Chief Compliance Officer	01-16	CI
Paratek Pharmaceuticals, Inc. Announces Board Changes	21/09/23	CI
Insider Buy: Paratek Pharmaceuticals	29/03/23	MT
Paratek Pharmaceuticals, Inc. Appoints Jeffrey Stein as First Lead Independent Director	20/12/22	CI
Paratek Pharmaceuticals, Inc. Appoints Minnie Baylor-Henry as an Independent Director and Audit Committee of its Board	14/06/21	CI
Insider Trends: Paratek Pharmaceuticals Insider Sale Scales Back 90-Days of Buys	16/12/20	MT
Insider Trends: 90-Day Insider Buying Trend Reduced with Disposition of Paratek Pharmaceuticals Shares	16/12/20	MT
Insider Trends: 90-Days of Insider Buying at Paratek Pharmaceuticals Eased Back with Share Disposition	16/12/20	MT
Insider Trends: Insider Sale at Paratek Pharmaceuticals Slowing 90-Days of Buying	16/12/20	MT
Paratek Pharmaceuticals, Inc. Announces Management Changes	25/06/19	CI
Paratek Pharmaceuticals, Inc. Announces Management Changes	18/03/19	CI
Paratek Pharmaceuticals, Inc. Appoints Rolf Hoffmann to Board of Directors	15/05/18	CI
Paratek Pharmaceuticals, Inc. Announces Board Changes	13/04/18	CI
Paratek Pharmaceuticals, Inc Announces Executive Changes	04/01/17	CI
Kris Peterson to Join Paratek Pharmaceuticals, Inc.'s Board of Directors	03/03/16	CI
Paratek Pharmaceuticals, Inc. Announces Executive Appointments	03/12/15	CI
Paratek Pharmaceuticals, Inc. Expands Leadership Team with Two New Hires	01/10/15	CI
Paratek Pharmaceuticals, Inc. Appoints Timothy Franson to its Board of Directors	22/07/15	CI
Paratek Pharmaceuticals, Inc. Appoints William Haskel as Senior Vice President, General Counsel and Corporate Secretary	01/07/15	CI
Paratek Pharmaceuticals, Inc. Announces Board Changes	03/06/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Transcept Pharmaceuticals Inc Nasdaq

Equities

US89354M1062

Insiders

Filters